Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug Administration in 2022 to revoke approval of a polio vaccine that is used widely in the U.
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering anti-smoking advocates.
Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon Musk, the world’s richest man. On paper, the department is tasked with modernizing federal technology and software; however, Trump and Musk have spent months boasting about how it will gut the federal government.
Class I, according to the FDA, means exposure to or consumption of the product could cause "serious adverse health consequences or death."
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.
After the Red No. 3 ban, there are now eight color additives approved by the FDA. They are FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, Orange B, Citrus Red No. 2, FD&C Red No. 40, FD&C Yellow No. 5 and FD&C Yellow No. 6.
The specifically recalled chips were: 13-ounce bags of Lay's Classic Potato Chips with UPC of 28400 31041, a "Guaranteed Fresh" date of Feb. 11, 2025, and a Manufacturing Code of either 6462307xx or 6463307xx. The batch was distributed in Washington and Oregon and the chips were available for purchase as soon as Nov. 3, 2024.
Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and iron sucrose, offer improved safety profiles and more efficient iron delivery compared with older compounds,